Clinical Trial Update: Effect of Oral and Intravenous Diltiazem Protocol for Emergency Department Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating an oral and intravenous diltiazem protocol for emergency department management of atrial fibrillation and atrial flutter; stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Diltiazem (diltiazem)

Snippet

Sponsor: Corewell Health South | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 4 | Status: COMPLETED | Results posted: 2024-12-27